The results have come back for Jon Jones’ drug tests prior to his UFC 235 fight with Anthony Smith this weekend, and as many expected, the same metabolite he has tested positive for in the past has popped up again.
On Thursday, the Nevada Athletic State Commission released the results of five different tests from Jones during the month of February. Two NSAC tests resulted in ‘adverse analytical findings’ of the M3 metabolite for oral-turinabol that has been in Jones’ system after a positive test back in July 2017, following his second fight with Daniel Cormier.
In the other tests, one USADA result came back clear, as did one VADA result. Another USADA sample taken on the 23rd of February is still pending. The positive NSAC tests were taken on consecutive days, the 14th and 15th of February, with one detecting 40 pg/mL and the other 20 pg/mL.
The president and director of the Sports Medicine and Research Laboratory, Dr. Daniel Eichner, concluded that due to the amount of the substance found in the two tests, Jones would hold no unfair advantage for his scheduled fight with Smith this weekend.
The NSAC re-licensed Jones for a single fight in late January, making him eligible to compete in the state of Nevada for his scheduled bout with Smith on March 2nd.
“The above analytical findings are consistent with the NSAC’s January 29, 2019 order to issue Mr. Jones a single fight license and, as such, the findings will not preclude him from competing on March 2, 2019,” The NAC’s statement read. “Mr. Jones will continue to be subject to random drug testing and monitoring so as to assure his continued compliance.”
UFC 235 will take place this Saturday at the T-Mobile Arena in Las Vegas. In addition to the light heavyweight title fight between Jones and Smith, the co-main event will feature a welterweight title fight between Tyron Woodley and Kamaru Usman.